Effectiveness, barriers, and facilitating factors of strategies for active delabeling of patients with penicillin allergy labels: a systematic review
Open Access
- 20 November 2025
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 54 (2) , 589-605
Abstract
Background: Penicillin allergy is the most frequently reported allergy in hospitalized patients, although rarely confirmed. Given the negative outcomes associated with incorrect penicillin allergy diagnoses, implementation of programmatic delabeling strategies is important for successful antibiotic stewardship. This systematic review evaluates the effectiveness of different delabeling strategies and highlights elements and settings that facilitate or constrict their implementation. Methods: Following the PRISMA-statement PubMed/MEDLINE, EMBASE, Cochrane Library, and grey literature databases “Worldcat” and “OpenGrey” were searched for studies reporting on interventions to identify, evaluate, or rule out incorrect penicillin allergy in hospitalized adults. Data extraction included settings, intervention types, and their effectiveness, barriers, facilitators, and regulatory factors. Results: This review included 42 studies, involving 6269 patients undergoing penicillin allergy delabeling, with 5017 (80%) successfully delabeled. Effectiveness varied from 32% to 99%. Skin testing had the highest success rate at 87%, followed by a combination of skin testing and oral challenge (84%), and direct oral challenges (77%). Direct delabeling alone had a lower effectiveness (67%), which improved to 80% when paired with oral challenges. Key facilitators included standardized algorithms and involvement of interdisciplinary teams. Barriers included patient refusal, staff resistance, time constraints, and financial limitations, particularly in smaller hospitals. Conclusion: Dependent on financial and staffing resources, oral challenges and direct delabeling after risk stratification may be alternatives to resource-intensive methods, such as skin testing, for successful delabeling. To address barriers to widespread delabeling implementation, patient and provider education must be improved, interprofessional collaboration enhanced, and standardized protocols developed.Keywords
Funding Information
- Universitätsklinikum Heidelberg
This publication has 72 references indexed in Scilit:
- Reaction Risk to Direct Penicillin ChallengesJAMA Internal Medicine, 2024
- Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trialIntensive Care Medicine, 2024
- Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savingsInternational Journal of Clinical Pharmacy, 2024
- Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin AllergyJAMA Internal Medicine, 2023
- Follow-up of penicillin allergy labels 1 year after successful penicillin delabelingAnnals of Allergy, Asthma & Immunology, 2022
- Expanding Penicillin Allergy Evaluation in Hospitalized PatientsThe American Journal of Medicine, 2022
- Development and Validation of a Penicillin Allergy Clinical Decision RuleJAMA Internal Medicine, 2020
- Evaluation and Management of Penicillin AllergyJAMA, 2019
- Penicillin skin testing in hospitalized patients with β-lactam allergiesAnnals of Allergy, Asthma & Immunology, 2016
- Costs of beta-Lactam Allergies: Selection and Costs of Antibiotics for Patients With a Reported beta-Lactam AllergyArchives of Family Medicine, 2000